Neuroendocrine tumor, NET is a rare disease of gastrointestinal tract and endocrine organs. There is increasing global incidence, together with the considerable number of people living with NET (estimated prevalence: 35 per 100,000). Besides the traditional surgery for tumor removal, could it be treated better with genomic profiling? The Digestive Endoscopy Society of Taiwan holds two NET medical seminars on 1/13 in Taichung for more discussions about the latest NET treatment strategy. ACT Genomics will share more about precision medicine in our display area and provide information of cancer genomic profiling services to physicians.